Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis

Area of Science:

• Cardiovascular Anesthesiology
• Cardiac Surgery
• Pharmacology

Background:

• Previous research suggests volatile anesthetic agents may offer myocardial protection during coronary artery bypass graft (CABG) surgery.
• Existing studies are limited by small sample sizes, hindering definitive conclusions on myocardial infarction (MI) and mortality.
• A systematic overview and meta-analysis are needed to consolidate evidence from randomized trials.

Purpose of the Study:

• To systematically review and meta-analyze randomized trials comparing volatile and non-volatile anesthesia in CABG surgery.
• To assess the impact of volatile anesthetics on myocardial protection, ischemia, MI, and mortality.
• To evaluate secondary outcomes including cardiac index, troponin levels, inotropic support, ventilation duration, and hospital length of stay.

Main Methods:

• Systematic overview and meta-analysis of 27 randomized trials.
• Inclusion of 2979 patients undergoing CABG surgery.
• Comparison of volatile anesthetic agents versus non-volatile (intravenous) anesthetics.

Main Results:

• No significant differences in myocardial ischemia, MI, ICU length of stay, or hospital mortality.
• Volatile anesthetics group showed higher cardiac indices (20%), lower troponin I levels, and reduced inotropic support post-bypass.
• Reduced mechanical ventilation duration (2.7 hours) and hospital length of stay (1 day) in the volatile anesthetic group.

Conclusions:

• Volatile anesthetic agents demonstrate potential for myocardial protection in CABG surgery, evidenced by improved hemodynamic and biochemical markers.
• Larger, adequately powered trials with predefined outcomes are necessary to definitively establish the effect of volatile anesthetics on MI and mortality risk.
• Current evidence suggests benefits in secondary outcomes, warranting further investigation into primary clinical endpoints.